COLPAL - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.2
| Stock Code | COLPAL | Market Cap | 57,383 Cr. | Current Price | 2,109 ₹ | High / Low | 2,904 ₹ |
| Stock P/E | 43.0 | Book Value | 58.2 ₹ | Dividend Yield | 2.42 % | ROCE | 105 % |
| ROE | 81.2 % | Face Value | 1.00 ₹ | DMA 50 | 2,136 ₹ | DMA 200 | 2,302 ₹ |
| Chg in FII Hold | -1.98 % | Chg in DII Hold | 1.55 % | PAT Qtr | 330 Cr. | PAT Prev Qtr | 328 Cr. |
| RSI | 47.6 | MACD | 3.88 | Volume | 2,43,886 | Avg Vol 1Wk | 5,53,566 |
| Low price | 2,029 ₹ | High price | 2,904 ₹ | PEG Ratio | 4.29 | Debt to equity | 0.04 |
| 52w Index | 9.12 % | Qtr Profit Var | 2.25 % | EPS | 48.8 ₹ | Industry PE | 46.8 |
📊 Financials: Colgate-Palmolive (India) Ltd. has reported PAT of 330 Cr compared to 328 Cr previously, reflecting stable earnings with a 2.25% quarterly profit variation. ROE at 81.2% and ROCE at 105% highlight exceptional efficiency. Debt-to-equity ratio of 0.04 indicates a virtually debt-free balance sheet, strengthening financial resilience. EPS of 48.8 ₹ supports earnings visibility, while cash flows remain robust given its strong consumer base.
💹 Valuation: Current P/E of 43.0 is slightly below the industry average (46.8), suggesting fair valuation. P/B ratio ~36.2 (Price 2,109 ₹ / Book Value 58.2 ₹) is expensive relative to book value. PEG ratio of 4.29 highlights stretched valuation compared to growth. Dividend yield of 2.42% provides attractive income support. Intrinsic value appears aligned with current price, offering stability but limited upside.
🏢 Business Model: Colgate-Palmolive operates in the FMCG sector, focusing on oral care products with dominant market share in toothpaste and toothbrush categories. Competitive advantage lies in brand strength, distribution reach, and recurring demand. The company benefits from consumer loyalty and consistent cash flows, though growth is constrained by market saturation.
📈 Entry Zone: Attractive accumulation zone between 2,050–2,100 ₹, near its 52-week low (2,029 ₹) and below DMA200 (2,302 ₹). RSI at 47.6 indicates neutral momentum, while MACD (3.88) suggests mild bullishness. Long-term investors can accumulate gradually at lower levels.
🔒 Holding Guidance: Fundamentally strong with debt-free operations, high ROE/ROCE, and strong dividend yield. Suitable for long-term holding, though valuations are stretched and growth prospects are modest.
Positive
- Exceptional ROE (81.2%) and ROCE (105%) highlight efficiency.
- Debt-free balance sheet (Debt-to-equity 0.04).
- Dividend yield of 2.42% provides attractive income support.
- Strong brand recognition and dominant market share in oral care.
- DII holdings increased (+1.55%), reflecting domestic confidence.
Limitation
- P/B ratio of 36.2 indicates expensive valuation relative to book value.
- PEG ratio of 4.29 highlights stretched valuation compared to growth.
- Growth prospects constrained by market saturation in oral care.
- FII holdings decreased (-1.98%), showing foreign caution.
Company Negative News
- No major negative news reported, but reduced FII holdings and limited growth prospects raise caution.
Company Positive News
- Stable quarterly PAT with consistent earnings.
- Debt-free operations strengthen financial resilience.
- Strong dividend yield supports investor confidence.
Industry
- FMCG sector benefits from recurring consumer demand and brand loyalty.
- Industry P/E at 46.8 suggests optimism in the sector.
- Oral care remains a defensive category with steady demand.
Conclusion
✅ Colgate-Palmolive (India) Ltd. is financially strong, debt-free, and efficient with dominant market share in oral care. Despite stretched valuations and modest growth prospects, its strong dividend yield and brand strength make it a stable long-term investment. Accumulation near 2,050–2,100 ₹ is recommended for patient investors.
Would you like me to extend this with a peer comparison against Hindustan Unilever and Dabur to highlight Colgate’s relative valuation and efficiency?